Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases

Class:IdLiteratureReference:9704129
_displayNamePharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases
_timestamp2020-10-07 13:54:09
author[Person:9704037] Salmon, Michael
[Person:9704165] Luttmann, Mark A
[Person:9704044] Foley, James J
[Person:9704046] Buckley, Peter T
[Person:9704192] Schmidt, Dulcie B
[Person:9704073] Burman, Miriam
[Person:9704000] Webb, Edward F
[Person:9704115] DeHaas, Christopher J
[Person:9703978] Kotzer, Charles J
[Person:9704162] Barrett, Victoria J
[Person:9704186] Slack, Robert J
[Person:9704156] Sarau, Henry M
[Person:9704070] Palovich, Michael R
[Person:9704113] Lainé, Dramane I
[Person:9704121] Hay, Douglas W P
[Person:9704048] Rumsey, William L
created[InstanceEdit:9704054] Jassal, Bijay, 2020-10-07
journalJ. Pharmacol. Exp. Ther.
pages260-70
pubMedIdentifier23435542
titlePharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases
volume345
year2013
(literatureReference)[Reaction:9704253] CHRM3 binds CHRM3 antagonists [Homo sapiens]
[Reaction:9704263] CHRM5 binds CHRM5 antagonists [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases (9704129)